As of November 6, 2026, Cellyan Biotechnology Co., Ltd is a publicly traded company (Nasdaq: HKPD). Liying Wang reports holding 65%, a majority of its shares. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D, November 12, 2025).
Is this your company?
About to sign with, pay or invest in Cellyan Biotechnology Co., Ltd? See the free Snapshot first.
Free to see. No signup.
Is Cellyan Biotechnology Co., Ltd a real, registered company?
- Hong Kong Pharma Digital Technology Holdings Limited files with the SEC under CIK 2007702 (its SEC filings).
- Its shares are listed under the ticker HKPD on Nasdaq (SEC company record).
- Incorporated in E9, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Hong Kong Pharma Digital Technology Holdings Limited in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Liying Wang (filed 2025-11-12).
Who are Cellyan Biotechnology Co., Ltd's owners and officers?
Cellyan Biotechnology Co., Ltd: industry Wholesale-Drugs, Proprietaries & Druggists' Sundries (F-1, 2026-03-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2025-11-12 | Liying Wang | 65% |
Want the whole picture on Cellyan Biotechnology Co., Ltd?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cellyan Biotechnology Co., Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cellyan Biotechnology Co., Ltd covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Cellyan Biotechnology Co., Ltd shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 18,468 shares (0.11% of shares outstanding) (Form 3, 2026-06-10).
Shares outstanding: 16,349,986 as of 2026-03-31, from the company's latest SEC cover page.
How much has Cellyan Biotechnology Co., Ltd raised?
Latest IPO step: Cellyan Biotechnology Co., Ltd filed to go public (F-1, 2026-03-27).
IPO filings: F-1, 2026-03-27, 424B4, 2025-01-15, F-1/A, 2024-12-10, F-1/A, 2024-11-27, F-1/A, 2024-11-21; ticker HKPD on Nasdaq.
Keep reading
More on Cellyan Biotechnology Co., Ltd and the records around it.
Cellyan Biotechnology Co., Ltd elsewhere on the record
- 5%+ stake filings Nov 2025
Companies that share a holder
- Liying Wang also filed stake reports on 1 other company: Nature Wood Group Ltd (Nov 2025)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/hong-kong-pharma-digital-technology